Instalab
logoInstalab

CAC Score RCA/PDA

See whether silent plaque is building in the artery feeding the underside of your heart, before symptoms ever appear.

Should you take a CAC Score RCA/PDA test?

This test is most useful if any of these apply to you.

Worried About Family History of Early Heart Disease
If a parent or sibling had a heart attack young, this scan shows whether plaque is already building in your arteries.
Healthy but Want to Stay Ahead
Your standard labs look fine, but you want to know what is happening inside your arteries before symptoms appear.
On the Fence About a Statin
If your cardiovascular risk is borderline, this scan can help decide whether to start lipid-lowering therapy now or wait.
Already Taking Heart Medications
If you take a statin or PCSK9 inhibitor, tracking this score over years shows whether plaque buildup is slowing.

About CAC Score RCA/PDA

Your heart is fed by three main coronary arteries, and the right coronary artery (RCA) plus its branch the posterior descending artery (PDA) supply the bottom and back wall of the heart in most people. A CT scan can pick out tiny specks of calcium in the walls of these vessels, and that calcium is a marker of plaque that has already been quietly building for years.

This score zooms in on calcified plaque in the RCA/PDA territory specifically. It is not a blood test and not a stress test. It is an anatomic snapshot of how much hardened atherosclerosis is sitting in one of the arteries whose blockage can cause a heart attack on the underside of the heart.

What This Score Actually Measures

A coronary artery calcium (CAC) scan uses a low-radiation CT to look for high-density spots in the artery walls. Each spot is scored by its area and a density weighting factor using a method called Agatston scoring, and lesions are summed across the coronary tree. Vessel-specific scoring adds up the calcium only in the RCA and its PDA branch, separately from the left-sided arteries.

Calcium in an artery wall is not the disease itself. It is part of the reparative process that follows atherosclerosis, and serves as a marker that plaque has been at work. So a number above zero in the RCA/PDA tells you that real plaque has been forming in the artery feeding the underside of your heart, even if your cholesterol panel and stress tests look fine.

Heart Attack and Major Cardiovascular Events

The strongest reason to know this number is that calcified plaque predicts future heart attacks, strokes, and cardiac death, independent of standard risk factors. Across a 10-year follow-up of 6,814 adults in the Multi-Ethnic Study of Atherosclerosis, total CAC strongly predicted atherosclerotic cardiovascular disease events regardless of age, sex, or ethnicity.

Where the calcium sits matters too. In the Framingham Heart Study cohort of community-dwelling adults, calcium concentrated in the proximal dominant coronary artery, which is the RCA in most people, independently predicted major coronary heart disease events. In a separate analysis of asymptomatic adults with mild calcium (scores of 1 to 99), proximal plaques in segments including the proximal RCA significantly predicted heart attack, late revascularization, or cardiac death.

In stable chest pain, a trial of 1,749 patients showed that a total CAC of zero indicated very low risk of major adverse cardiovascular events, while higher scores tracked sharply with obstructive coronary disease, revascularization, and events over follow-up. Calcium in the RCA/PDA territory is one piece of that total picture.

Obstructive Disease in the Right Coronary System

Calcium in the RCA/PDA branch can also flag arteries narrow enough to limit blood flow. In a CT angiography study of 1,000 people, coronary anatomy and disease evaluation provided extra information about risk in patients with right coronary involvement and obstructive disease that stenosis alone did not capture.

An automated segment-level deep-learning scoring system tested in 1,514 scans showed its highest detection accuracy for plaque in the proximal RCA (sensitivity 0.94) and distal RCA (0.92), which means modern CT scoring is well-suited to picking up calcium in this specific vessel.

All-Cause Mortality

Higher coronary calcium is linked to dying earlier from any cause, not just heart events. In a study of 5,678 adults with incidental calcium found on routine non-cardiac CTs, a score of 100 or more was associated with more than twice the risk of all-cause death and adverse cardiovascular events, beyond traditional risk factors.

Among adults aged 32 to 46 in a cohort of 5,115, any detectable calcium raised the risk of coronary heart disease, and scores of 100 or more were associated with higher all-cause mortality, mainly driven by coronary heart disease. The RCA/PDA component contributes to that total burden.

Calcium in Younger Adults and the Power of Zero

A CAC score of zero overall is one of the most powerful negative findings in cardiology. In stable chest pain, zero calcium indicated very low short-term event risk. The same logic applies vessel by vessel: no calcium in the RCA/PDA means no hardened plaque has been deposited there yet.

There is one important caveat for younger people. In a study of 1,372 patients referred for preventive screening, a total CAC of zero did not reliably exclude coronary plaque in younger adults. That fits with broader evidence that non-calcified plaque can exist before calcium shows up (estimated in roughly 1 in 10 people with zero CAC, and more often in those with multiple risk factors), so the meaning of a zero is stronger after middle age than before it.

Why a Single Reading Is Only the Start

Calcium scores are reproducible measurements of a slowly changing structural marker, so you do not need to repeat them every few months. What matters is the trajectory over years. A baseline scan tells you where you are right now. A follow-up scan years later tells you whether your prevention plan is actually slowing the deposition of new calcified plaque, or whether you need a more aggressive approach.

A reasonable cadence for many proactive adults is a baseline scan now if you are 40 or older (earlier with strong family history), and a repeat scan in 3 to 5 years if the first one is zero or low, sooner if calcium is already present and you are making major changes to lipids, blood pressure, or weight.

One nuance to know: people on statins often show rising calcium scores over time even though the drug is reducing their actual risk of heart events. Serial CT angiography work in 654 patients showed that statin use shifts plaque toward the calcified, more stable form. So a rising calcium score on a statin is not necessarily bad news. It can reflect plaque stabilization rather than worsening disease.

Reconciling Two Findings That Seem to Contradict

Two patterns may look contradictory at first. Higher calcium predicts more events. Statins increase calcium but lower events. The resolution: calcium is a marker of cumulative atherosclerotic exposure, while the type of calcium and the activity of the underlying plaque determine vulnerability. Statins delipidate atherosclerotic plaque, converting lipid-rich, vulnerable plaque into denser, more stable calcified plaque. So the right way to read a rising score on therapy is as a sign of plaque stabilization, not a sign of failing treatment, especially when your lipids and other markers are improving.

When Results Can Be Misleading

Calcium scoring captures only one component of atherosclerosis. A few situations can lead you astray if you treat a single number as the whole story:

  • Soft plaque in younger adults: in patients referred for preventive screening, a zero score did not reliably exclude coronary plaque in younger people, because plaque can be present in a non-calcified form before it ever shows up on CT.
  • Statin therapy in progress: statins are consistently associated with higher calcium scores over time, even as they lower the risk of heart attacks. A rising number on a statin can reflect plaque becoming more stable rather than disease worsening.
  • Scan quality and method: segment-level accuracy varies, with the highest detection in the proximal and distal RCA and lower sensitivity in some other segments. The scanner, protocol, and reader all influence the final number.
  • A normal stress test or normal lipid panel does not equal low calcium: stress imaging detects narrowed arteries blocking flow, while calcium scoring detects plaque buildup itself. CAC has caught coronary disease that perfusion testing missed.

Decision Pathway for an Unexpected Result

If your RCA/PDA calcium is above zero and you were not expecting it, the next step is not to panic and not to ignore it. The combination of findings drives the action. Pair the score with a full lipid panel including ApoB and Lp(a), inflammatory markers, blood pressure, and a careful family history. Any calcium plus elevated ApoB or Lp(a) is a strong case for aggressive lipid-lowering.

If the RCA/PDA score is high and you have stable symptoms, a referral to a cardiologist or a follow-up CT angiogram can clarify whether any of the calcified plaque is also obstructing blood flow. If the overall calcium pattern is heavy and concentrated in proximal segments, that combination is a stronger event predictor than the same total score scattered diffusely, and earlier and more intensive prevention is appropriate.

If the score is zero and you are over 50, that is genuinely reassuring information, though it does not erase the need to manage cholesterol, blood pressure, glucose, and smoking. If you are under 45 and the score is zero, take it as a useful baseline rather than an all-clear, because soft plaque can exist before calcium develops.

What Moves This Biomarker

Evidence-backed interventions that affect your CAC Score RCA/PDA level

Increase
Cigarette smoking
Smoking damages the artery wall and drives true atherosclerosis, leading to more calcified plaque over time. In a study of 1,181 veterans, severe coronary calcification was strongly linked to significant smoking history. This is one of the few exposures that both raises your calcium score and unambiguously raises your risk of heart attack and death.
LifestyleStrong Evidence
Increase
Statin therapy
Statins raise the calcium number on your scan over time, but this reflects plaque becoming more stable, not worsening disease. In serial CT angiography of 654 patients, statin use shifted plaque toward the calcified form, and a post-hoc analysis of 8 randomized trials confirmed that statins promote coronary atheroma calcification independent of their plaque-regressive effects. Longer statin duration was linked to markedly higher odds of severe calcium scores in a study of 1,181 veterans, alongside the well-established reduction in cardiovascular events.
MedicationModerate Evidence
Decrease
Alirocumab (PCSK9 inhibitor) added to statin
Adding the cholesterol-lowering injection alirocumab on top of a statin was associated with slowed coronary calcification progression in a small randomized trial of patients with coronary artery disease, compared with statin alone. A larger trial (PACMAN-AMI) showed alirocumab on top of high-intensity statin produced greater overall plaque regression, reduced lipid content, and increased fibrous cap thickness, suggesting more aggressive lipid lowering can blunt plaque progression.
MedicationModest Evidence
Increase
High-volume vigorous physical activity
The relationship between exercise volume and calcium score is mixed. In a cohort of 25,485 seemingly healthy adults, more physical activity tracked with faster calcium progression, and in middle-aged athletes, very vigorous exercise was associated with more calcium and plaque progression. However, a more recent longitudinal study of 8,771 adults (Cooper Clinic, 2024) found that physical activity volume was not associated with CAC progression. The current understanding is that exercise-related calcified plaque tends to be denser and more stable, which is why heavy exercisers still have lower overall cardiovascular mortality.
ExerciseModest Evidence

Frequently Asked Questions

References

20 studies
  1. Greenland P, Blaha M, Budoff M, Erbel R, Watson KJournal of the American College of Cardiology2018
  2. Budoff M, Young RL, Burke G, Carr JJ, Detrano R, Folsom a, Kronmal R, Lima J, Liu K, Mcclelland R, Michos E, Post W, Shea S, Watson K, Wong NEuropean Heart Journal2018
  3. Ferencik M, Pencina K, Liu T, Ghemigian K, Baltrusaitis K, Massaro J, D'agostino R, O'donnell C, Hoffmann UCirculation: Cardiovascular Imaging2017
  4. Tummala R, Han D, Friedman J, Hayes S, Thomson L, Gransar H, Slomka P, Rozanski a, Dey D, Berman DAmerican Journal of Preventive Cardiology2022
  5. Biavati F, Saba L, Boussoussou M, Kofoed KF, Benedek T, Donnelly P, Dewey MRadiology2024